10-Q Filing

COMMUNITY HEALTH SYSTEMS INC CIK: 1108109 Q2 2018

Filing Information

Form Type	10-Q
Accession Number	`0001193125-18-229648`
Period End Date	20180630
Filing Date	20180727
Fiscal Year	2018
Fiscal Period	Q2
XBRL Instance	cyh-20180630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 84 Income Statement 117 Cash Flow Statement 84 Comprehensive Income 32

Balance Sheet 84 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value per share	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value per share	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$238.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$768.00M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$208.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$563.00M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Patient accounts receivable (see Note 1)	`AccountsReceivableNetCurrent`	$2.38B	USD	Point-in-time
Common stock, par value per share	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Patient accounts receivable (see Note 1)	`AccountsReceivableNetCurrent`	$2.41B	USD	Point-in-time
Common stock, par value per share	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Supplies	`Supplies`	$432.00M	USD	Point-in-time
Supplies	`Supplies`	$444.00M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	114.65M	shares	Point-in-time
Prepaid income taxes	`PrepaidTaxes`	$17.00M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	116.26M	shares	Point-in-time
Prepaid income taxes	`PrepaidTaxes`	$8.00M	USD	Point-in-time
Prepaid expenses and taxes	`PrepaidExpensesAndTaxes`	$217.00M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	114.65M	shares	Point-in-time
Prepaid expenses and taxes	`PrepaidExpensesAndTaxes`	$198.00M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	116.26M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$422.00M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$462.00M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$4.07B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$3.69B	USD	Point-in-time
Property and equipment	`PropertyPlantAndEquipmentGross`	$11.15B	USD	Point-in-time
Property and equipment	`PropertyPlantAndEquipmentGross`	$11.50B	USD	Point-in-time
Less accumulated depreciation and amortization	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$4.45B	USD	Point-in-time
Less accumulated depreciation and amortization	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$4.40B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$6.75B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$7.05B	USD	Point-in-time
Goodwill	`Goodwill`	$4.72B	USD	Point-in-time
Goodwill	`Goodwill`	$4.65B	USD	Point-in-time
Deferred income taxes	`DeferredTaxAssetsNetNoncurrent`	$101.00M	USD	Point-in-time
Deferred income taxes	`DeferredTaxAssetsNetNoncurrent`	$62.00M	USD	Point-in-time
Other assets, net	`OtherAssetsNoncurrent`	$1.54B	USD	Point-in-time
Other assets, net	`OtherAssetsNoncurrent`	$1.60B	USD	Point-in-time
Total assets	`Assets`	$17.45B	USD	Point-in-time
Total assets	`Assets`	$16.79B	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$33.00M	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$41.00M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$967.00M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$839.00M	USD	Point-in-time
Employee compensation	`EmployeeRelatedLiabilitiesCurrent`	$592.00M	USD	Point-in-time
Employee compensation	`EmployeeRelatedLiabilitiesCurrent`	$685.00M	USD	Point-in-time
Accrued interest	`InterestPayableCurrent`	$229.00M	USD	Point-in-time
Accrued interest	`InterestPayableCurrent`	$174.00M	USD	Point-in-time
Other	`OtherAccruedLiabilitiesCurrent`	$442.00M	USD	Point-in-time
Other	`OtherAccruedLiabilitiesCurrent`	$416.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.06B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.36B	USD	Point-in-time
Long-term debt	`LongTermDebtAndCapitalLeaseObligations`	$13.88B	USD	Point-in-time
Long-term debt	`LongTermDebtAndCapitalLeaseObligations`	$13.67B	USD	Point-in-time
Deferred income taxes	`DeferredTaxLiabilitiesNoncurrent`	$19.00M	USD	Point-in-time
Deferred income taxes	`DeferredTaxLiabilitiesNoncurrent`	$19.00M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$1.33B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$1.36B	USD	Point-in-time
Total liabilities	`Liabilities`	$17.61B	USD	Point-in-time
Total liabilities	`Liabilities`	$17.08B	USD	Point-in-time
Redeemable noncontrolling interests in equity of consolidated subsidiaries	`RedeemableNoncontrollingInterestEquityFairValue`	$514.00M	USD	Point-in-time
Redeemable noncontrolling interests in equity of consolidated subsidiaries	`RedeemableNoncontrollingInterestEquityFairValue`	$527.00M	USD	Point-in-time
Preferred stock, $.01 par value per share, 100,000,000 shares authorized; none issued	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.01 par value per share, 100,000,000 shares authorized; none issued	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.01 par value per share, 300,000,000 shares authorized; 116,261,738 shares issued and outstanding at June 30, 2018, and 114,651,004 shares issued and outstanding at December 31, 2017	`CommonStockValue`	$1.00M	USD	Point-in-time
Common stock, $.01 par value per share, 300,000,000 shares authorized; 116,261,738 shares issued and outstanding at June 30, 2018, and 114,651,004 shares issued and outstanding at December 31, 2017	`CommonStockValue`	$1.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.01B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.01B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-9.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-21.00M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-2.76B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-2.88B	USD	Point-in-time
Total Community Health Systems, Inc. stockholders' deficit	`StockholdersEquity`	$-767.00M	USD	Point-in-time
Total Community Health Systems, Inc. stockholders' deficit	`StockholdersEquity`	$-879.00M	USD	Point-in-time
Noncontrolling interests in equity of consolidated subsidiaries	`MinorityInterest`	$75.00M	USD	Point-in-time
Noncontrolling interests in equity of consolidated subsidiaries	`MinorityInterest`	$76.00M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-803.00M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-692.00M	USD	Point-in-time
Total liabilities and stockholders' deficit	`LiabilitiesAndStockholdersEquity`	$16.79B	USD	Point-in-time
Total liabilities and stockholders' deficit	`LiabilitiesAndStockholdersEquity`	$17.45B	USD	Point-in-time

Income Statement 117 line items

Line Item	Tag	Value	Unit	Period
Operating revenues (net of contractual allowances and discounts)	`HealthCareOrganizationRevenue`	$9.99B	USD	2 Qtrs
Operating revenues (net of contractual allowances and discounts)	`HealthCareOrganizationRevenue`	$4.82B	USD	1 Quarter
Provision for bad debts	`HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts`	$679.00M	USD	1 Quarter
Provision for bad debts	`HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts`	$1.36B	USD	2 Qtrs
Net operating revenues (see Note 1)	`Revenues`	$4.14B	USD	1 Quarter
Net operating revenues (see Note 1)	`Revenues`	$8.63B	USD	2 Qtrs
Net operating revenues (see Note 1)	`Revenues`	$3.56B	USD	1 Quarter
Net operating revenues (see Note 1)	`Revenues`	$7.25B	USD	2 Qtrs
Salaries and benefits	`LaborAndRelatedExpense`	$1.62B	USD	1 Quarter
Salaries and benefits	`LaborAndRelatedExpense`	$1.92B	USD	1 Quarter
Salaries and benefits	`LaborAndRelatedExpense`	$3.27B	USD	2 Qtrs
Salaries and benefits	`LaborAndRelatedExpense`	$3.98B	USD	2 Qtrs
Supplies	`HealthCareOrganizationMedicalSuppliesAndDrugsExpense`	$697.00M	USD	1 Quarter
Supplies	`HealthCareOrganizationMedicalSuppliesAndDrugsExpense`	$1.21B	USD	2 Qtrs
Supplies	`HealthCareOrganizationMedicalSuppliesAndDrugsExpense`	$592.00M	USD	1 Quarter
Supplies	`HealthCareOrganizationMedicalSuppliesAndDrugsExpense`	$1.45B	USD	2 Qtrs
Other operating expenses	`OtherCostAndExpenseOperating`	$879.00M	USD	1 Quarter
Other operating expenses	`OtherCostAndExpenseOperating`	$2.07B	USD	2 Qtrs
Other operating expenses	`OtherCostAndExpenseOperating`	$1.02B	USD	1 Quarter
Other operating expenses	`OtherCostAndExpenseOperating`	$1.79B	USD	2 Qtrs
Government and other legal settlements and related costs	`GainLossRelatedToLitigationSettlement`	$-7.00M	USD	2 Qtrs
Government and other legal settlements and related costs	`GainLossRelatedToLitigationSettlement`	$-1.00M	USD	1 Quarter
Government and other legal settlements and related costs	`GainLossRelatedToLitigationSettlement`	$34.00M	USD	2 Qtrs
Government and other legal settlements and related costs	`GainLossRelatedToLitigationSettlement`	$-7.00M	USD	1 Quarter
Electronic health records incentive reimbursement	`ElectronicHealthRecordsIncentiveReimbursement`	$17.00M	USD	1 Quarter
Electronic health records incentive reimbursement	`ElectronicHealthRecordsIncentiveReimbursement`	$1.00M	USD	2 Qtrs
Electronic health records incentive reimbursement	`ElectronicHealthRecordsIncentiveReimbursement`	$23.00M	USD	2 Qtrs
Rent	`LeaseAndRentalExpense`	$104.00M	USD	1 Quarter
Rent	`LeaseAndRentalExpense`	$173.00M	USD	2 Qtrs
Rent	`LeaseAndRentalExpense`	$85.00M	USD	1 Quarter
Rent	`LeaseAndRentalExpense`	$214.00M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$358.00M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$223.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$177.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$458.00M	USD	2 Qtrs
Impairment and (gain) loss on sale of businesses, net	`AssetImpairmentCharges`	$174.00M	USD	1 Quarter
Impairment and (gain) loss on sale of businesses, net	`AssetImpairmentCharges`	$202.00M	USD	2 Qtrs
Impairment and (gain) loss on sale of businesses, net	`AssetImpairmentCharges`	$80.00M	USD	1 Quarter
Impairment and (gain) loss on sale of businesses, net	`AssetImpairmentCharges`	$330.00M	USD	2 Qtrs
Total operating costs and expenses	`CostsAndExpenses`	$3.52B	USD	1 Quarter
Total operating costs and expenses	`CostsAndExpenses`	$4.03B	USD	1 Quarter
Total operating costs and expenses	`CostsAndExpenses`	$7.00B	USD	2 Qtrs
Total operating costs and expenses	`CostsAndExpenses`	$8.45B	USD	2 Qtrs
Income from operations	`OperatingIncomeLoss`	$250.00M	USD	2 Qtrs
Income from operations	`OperatingIncomeLoss`	$113.00M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$37.00M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$183.00M	USD	2 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-235.00M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-464.00M	USD	2 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-468.00M	USD	2 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-239.00M	USD	1 Quarter
(Gain) loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-31.00M	USD	2 Qtrs
(Gain) loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-10.00M	USD	1 Quarter
(Gain) loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$64.00M	USD	1 Quarter
(Gain) loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$59.00M	USD	2 Qtrs
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$5.00M	USD	1 Quarter
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$9.00M	USD	2 Qtrs
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$12.00M	USD	2 Qtrs
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$5.00M	USD	1 Quarter
Loss from continuing operations before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-143.00M	USD	2 Qtrs
Loss from continuing operations before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-129.00M	USD	1 Quarter
Loss from continuing operations before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-131.00M	USD	1 Quarter
Loss from continuing operations before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-307.00M	USD	2 Qtrs
Benefit from income taxes	`IncomeTaxExpenseBenefit`	$-15.00M	USD	1 Quarter
Benefit from income taxes	`IncomeTaxExpenseBenefit`	$-45.00M	USD	2 Qtrs
Benefit from income taxes	`IncomeTaxExpenseBenefit`	$-38.00M	USD	1 Quarter
Benefit from income taxes	`IncomeTaxExpenseBenefit`	$-15.00M	USD	2 Qtrs
Loss from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-98.00M	USD	2 Qtrs
Loss from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-116.00M	USD	1 Quarter
Loss from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-91.00M	USD	1 Quarter
Loss from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-292.00M	USD	2 Qtrs
Loss from operations of entities sold or held for sale	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax`	$-2.00M	USD	2 Qtrs
Loss from operations of entities sold or held for sale	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax`	$-1.00M	USD	1 Quarter
Impairment of hospitals sold or held for sale	`DiscontinuedOperationProvisionForLossGainOnDisposalNetOfTax`	$5.00M	USD	1 Quarter
Impairment of hospitals sold or held for sale	`DiscontinuedOperationProvisionForLossGainOnDisposalNetOfTax`	$5.00M	USD	2 Qtrs
Loss from discontinued operations, net of taxes	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-7.00M	USD	2 Qtrs
Loss from discontinued operations, net of taxes	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-6.00M	USD	1 Quarter
Net loss	`ProfitLoss`	$-91.00M	USD	1 Quarter
Net loss	`ProfitLoss`	$-299.00M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-98.00M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-122.00M	USD	1 Quarter
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$37.00M	USD	2 Qtrs
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$15.00M	USD	1 Quarter
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$19.00M	USD	1 Quarter
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$36.00M	USD	2 Qtrs
Net loss attributable to Community Health Systems, Inc. stockholders	`NetIncomeLoss`	$-110.00M	USD	1 Quarter
Net loss attributable to Community Health Systems, Inc. stockholders	`NetIncomeLoss`	$-137.00M	USD	1 Quarter
Net loss attributable to Community Health Systems, Inc. stockholders	`NetIncomeLoss`	$-335.00M	USD	2 Qtrs
Net loss attributable to Community Health Systems, Inc. stockholders	`NetIncomeLoss`	$-135.00M	USD	2 Qtrs
Continuing operations	`IncomeLossFromContinuingOperationsPerBasicShare`	$-1.17	USD	1 Quarter
Continuing operations	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.97	USD	1 Quarter
Continuing operations	`IncomeLossFromContinuingOperationsPerBasicShare`	$-1.20	USD	2 Qtrs
Continuing operations	`IncomeLossFromContinuingOperationsPerBasicShare`	$-2.94	USD	2 Qtrs
Discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$-0.06	USD	1 Quarter
Discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$-0.06	USD	2 Qtrs
Net loss	`EarningsPerShareBasic`	$-0.97	USD	1 Quarter
Net loss	`EarningsPerShareBasic`	$-3.01	USD	2 Qtrs
Net loss	`EarningsPerShareBasic`	$-1.22	USD	1 Quarter
Net loss	`EarningsPerShareBasic`	$-1.20	USD	2 Qtrs
Continuing operations	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-1.20	USD	2 Qtrs
Continuing operations	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-2.94	USD	2 Qtrs
Continuing operations	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-1.17	USD	1 Quarter
Continuing operations	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.97	USD	1 Quarter
Discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$-0.06	USD	2 Qtrs
Discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$-0.06	USD	1 Quarter
Net loss	`EarningsPerShareDiluted`	$-3.01	USD	2 Qtrs
Net loss	`EarningsPerShareDiluted`	$-0.97	USD	1 Quarter
Net loss	`EarningsPerShareDiluted`	$-1.20	USD	2 Qtrs
Net loss	`EarningsPerShareDiluted`	$-1.22	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	112.57M	shares	2 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	112.84M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	111.91M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	111.58M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	112.84M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	111.58M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	111.91M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	112.57M	shares	2 Qtrs

Cash Flow Statement 84 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-91.00M	USD	1 Quarter
Net loss	`ProfitLoss`	$-299.00M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-98.00M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-122.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$358.00M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$458.00M	USD	2 Qtrs
Government and other legal settlements and related costs	`LossContingencyAccrualProvisionNonCash`	$7.00M	USD	2 Qtrs
Government and other legal settlements and related costs	`LossContingencyAccrualProvisionNonCash`	$6.00M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$6.00M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$7.00M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$15.00M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$3.00M	USD	1 Quarter
Impairment of hospitals sold or held for sale	`ImpairmentOfLongLivedAssetsToBeDisposedOfOrSold`	$5.00M	USD	2 Qtrs
Impairment and (gain) loss on sale of businesses, net	`ImpairmentOfLongLivedAssetsHeldForUse`	$330.00M	USD	2 Qtrs
Impairment and (gain) loss on sale of businesses, net	`ImpairmentOfLongLivedAssetsHeldForUse`	$202.00M	USD	2 Qtrs
(Gain) loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-31.00M	USD	2 Qtrs
(Gain) loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-10.00M	USD	1 Quarter
(Gain) loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$64.00M	USD	1 Quarter
(Gain) loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$59.00M	USD	2 Qtrs
Other non-cash expenses, net	`OtherNoncashIncomeExpense`	$-23.00M	USD	2 Qtrs
Other non-cash expenses, net	`OtherNoncashIncomeExpense`	$-18.00M	USD	2 Qtrs
Patient accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$21.00M	USD	2 Qtrs
Patient accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-186.00M	USD	2 Qtrs
Supplies, prepaid expenses and other current assets	`IncreaseDecreaseInSuppliesPrepaidExpensesAndOtherCurrentAssets`	$15.00M	USD	2 Qtrs
Supplies, prepaid expenses and other current assets	`IncreaseDecreaseInSuppliesPrepaidExpensesAndOtherCurrentAssets`	$55.00M	USD	2 Qtrs
Accounts payable, accrued liabilities and income taxes	`IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndIncomeTaxes`	$-126.00M	USD	2 Qtrs
Accounts payable, accrued liabilities and income taxes	`IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndIncomeTaxes`	$-308.00M	USD	2 Qtrs
Other	`IncreaseDecreaseInOtherOperatingCapitalNet`	$66.00M	USD	2 Qtrs
Other	`IncreaseDecreaseInOtherOperatingCapitalNet`	$2.00M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$94.00M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$503.00M	USD	2 Qtrs
Acquisitions of facilities and other related businesses	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$4.00M	USD	2 Qtrs
Acquisitions of facilities and other related businesses	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$10.00M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$274.00M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$295.00M	USD	2 Qtrs
Proceeds from disposition of hospitals and other ancillary operations	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	$88.00M	USD	2 Qtrs
Proceeds from disposition of hospitals and other ancillary operations	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	$921.00M	USD	2 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$3.00M	USD	2 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$4.00M	USD	2 Qtrs
Purchases of available-for-sale securities and equity securities	`PaymentsToAcquireInvestments`	$38.00M	USD	2 Qtrs
Purchases of available-for-sale securities and equity securities	`PaymentsToAcquireInvestments`	$37.00M	USD	2 Qtrs
Proceeds from sales of available-for-sale securities and equity securities	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$63.00M	USD	2 Qtrs
Proceeds from sales of available-for-sale securities and equity securities	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$47.00M	USD	2 Qtrs
Increase in other investments	`PaymentsForProceedsFromOtherInvestingActivities`	$60.00M	USD	2 Qtrs
Increase in other investments	`PaymentsForProceedsFromOtherInvestingActivities`	$53.00M	USD	2 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$596.00M	USD	2 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-241.00M	USD	2 Qtrs
Repurchase of restricted stock shares for payroll tax withholding requirements	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$5.00M	USD	2 Qtrs
Repurchase of restricted stock shares for payroll tax withholding requirements	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$1.00M	USD	2 Qtrs
Deferred financing costs and other debt-related costs	`PaymentsOfFinancingCosts`	$54.00M	USD	2 Qtrs
Deferred financing costs and other debt-related costs	`PaymentsOfFinancingCosts`	$62.00M	USD	2 Qtrs
Proceeds from noncontrolling investors in joint ventures	`ProceedsFromDivestitureOfInterestInJointVenture`	$5.00M	USD	2 Qtrs
Proceeds from noncontrolling investors in joint ventures	`ProceedsFromDivestitureOfInterestInJointVenture`	$1.00M	USD	2 Qtrs
Redemption of noncontrolling investments in joint ventures	`PaymentsToMinorityShareholders`	$6.00M	USD	2 Qtrs
Redemption of noncontrolling investments in joint ventures	`PaymentsToMinorityShareholders`	$4.00M	USD	2 Qtrs
Distributions to noncontrolling investors in joint ventures	`PaymentsOfDividendsMinorityInterest`	$53.00M	USD	2 Qtrs
Distributions to noncontrolling investors in joint ventures	`PaymentsOfDividendsMinorityInterest`	$52.00M	USD	2 Qtrs
Borrowings under credit agreements	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$26.00M	USD	2 Qtrs
Borrowings under credit agreements	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$840.00M	USD	2 Qtrs
Issuance of long-term debt	`ProceedsFromIssuanceOfSubordinatedLongTermDebt`	$3.10B	USD	2 Qtrs
Proceeds from ABL and receivables facility	`ProceedsFromAccountsReceivableSecuritization`	$26.00M	USD	2 Qtrs
Proceeds from ABL and receivables facility	`ProceedsFromAccountsReceivableSecuritization`	$587.00M	USD	2 Qtrs
Repayments of long-term indebtedness	`RepaymentsOfLongTermDebt`	$4.42B	USD	2 Qtrs
Repayments of long-term indebtedness	`RepaymentsOfLongTermDebt`	$709.00M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-208.00M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-569.00M	USD	2 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$530.00M	USD	2 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-355.00M	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$238.00M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$768.00M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$208.00M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$563.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$238.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$768.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$208.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$563.00M	USD	Point-in-time
Interest payments	`InterestPaidNet`	$130.00M	USD	1 Quarter
Interest payments	`InterestPaidNet`	$486.00M	USD	2 Qtrs
Interest payments	`InterestPaidNet`	$274.00M	USD	1 Quarter
Interest payments	`InterestPaidNet`	$409.00M	USD	2 Qtrs
Income tax (payments) refunds, net	`IncomeTaxesPaidNet`	$-9.00M	USD	2 Qtrs
Income tax (payments) refunds, net	`IncomeTaxesPaidNet`	$-9.00M	USD	1 Quarter
Income tax (payments) refunds, net	`IncomeTaxesPaidNet`	$6.00M	USD	2 Qtrs
Income tax (payments) refunds, net	`IncomeTaxesPaidNet`	$5.00M	USD	1 Quarter

Comprehensive Income 32 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-91.00M	USD	1 Quarter
Net loss	`ProfitLoss`	$-299.00M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-98.00M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-122.00M	USD	1 Quarter
Net change in fair value of interest rate swaps, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$7.00M	USD	1 Quarter
Net change in fair value of interest rate swaps, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$3.00M	USD	2 Qtrs
Net change in fair value of interest rate swaps, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-2.00M	USD	1 Quarter
Net change in fair value of interest rate swaps, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$25.00M	USD	2 Qtrs
Net change in fair value of available-for-sale securities, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$5.00M	USD	2 Qtrs
Net change in fair value of available-for-sale securities, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-2.00M	USD	2 Qtrs
Net change in fair value of available-for-sale securities, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$2.00M	USD	1 Quarter
Net change in fair value of available-for-sale securities, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-1.00M	USD	1 Quarter
Amortization and recognition of unrecognized pension cost, net of tax	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-1.00M	USD	2 Qtrs
Amortization and recognition of unrecognized pension cost, net of tax	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-1.00M	USD	2 Qtrs
Amortization and recognition of unrecognized pension cost, net of tax	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-1.00M	USD	1 Quarter
Amortization and recognition of unrecognized pension cost, net of tax	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-1.00M	USD	1 Quarter
Other comprehensive income	`OtherComprehensiveIncomeLossNetOfTax`	$1.00M	USD	1 Quarter
Other comprehensive income	`OtherComprehensiveIncomeLossNetOfTax`	$7.00M	USD	1 Quarter
Other comprehensive income	`OtherComprehensiveIncomeLossNetOfTax`	$9.00M	USD	2 Qtrs
Other comprehensive income	`OtherComprehensiveIncomeLossNetOfTax`	$24.00M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-290.00M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-74.00M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-121.00M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-84.00M	USD	1 Quarter
Less: Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$15.00M	USD	1 Quarter
Less: Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$37.00M	USD	2 Qtrs
Less: Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$19.00M	USD	1 Quarter
Less: Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$36.00M	USD	2 Qtrs
Comprehensive loss attributable to Community Health Systems, Inc. stockholders	`ComprehensiveIncomeNetOfTax`	$-111.00M	USD	2 Qtrs
Comprehensive loss attributable to Community Health Systems, Inc. stockholders	`ComprehensiveIncomeNetOfTax`	$-136.00M	USD	1 Quarter
Comprehensive loss attributable to Community Health Systems, Inc. stockholders	`ComprehensiveIncomeNetOfTax`	$-326.00M	USD	2 Qtrs
Comprehensive loss attributable to Community Health Systems, Inc. stockholders	`ComprehensiveIncomeNetOfTax`	$-103.00M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.